163 related articles for article (PubMed ID: 10930966)
21. Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy.
Dunphy FR; Harrison BR; Dunleavy TL; Rodriguez JJ; Hilton JG; Boyd JH
Cancer; 1999 Oct; 86(7):1362-7. PubMed ID: 10506726
[TBL] [Abstract][Full Text] [Related]
22. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
23. Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients.
Kangarloo SB; Gangopadhyay SB; Syme RM; Wolff JE; Glück S
Med Oncol; 2004; 21(1):9-20. PubMed ID: 15034209
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
25. Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity.
Awada A; Dumez H; Aftimos PG; Costermans J; Bartholomeus S; Forceville K; Berghmans T; Meeus MA; Cescutti J; Munzert G; Pilz K; Liu D; Schöffski P
Invest New Drugs; 2015 Jun; 33(3):611-20. PubMed ID: 25794535
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of 5-fluorouracil combined with carboplatin in patients with head and neck cancer.
Wihlm J; Leveque D; Klein T
Anticancer Res; 1994; 14(6A):2395-6. PubMed ID: 7825979
[TBL] [Abstract][Full Text] [Related]
27. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
[TBL] [Abstract][Full Text] [Related]
28. Tissue platinum after clinical treatment with cisplatin or carboplatin in tumor-bearing patients.
Minami T; Tohno Y; Tohno S; Utsumi M; Yamada M; Hashii K; Tateyama I; Kadota E; Okazaki Y
Biol Trace Elem Res; 1997; 58(1-2):77-83. PubMed ID: 9363322
[TBL] [Abstract][Full Text] [Related]
29. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
[TBL] [Abstract][Full Text] [Related]
30. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
Bowden NA
Cancer Lett; 2014 May; 346(2):163-71. PubMed ID: 24462818
[TBL] [Abstract][Full Text] [Related]
32. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.
Stewart L;
Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788
[TBL] [Abstract][Full Text] [Related]
34. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487
[TBL] [Abstract][Full Text] [Related]
35. [Optimization using the pharmacokinetics of the therapeutic index of CDDP-5 FU treatment over 5 continuous days].
Milano G; Santini J; Thyss A; Reneè N; Veins P; Chauvel P; Schneider M; Demard F
Bull Cancer; 1989; 76(8):905-8. PubMed ID: 2620123
[No Abstract] [Full Text] [Related]
36. Erythropoietin response is inadequate in cancer patients receiving chemotherapy.
Lee SJ; Kwon JH; Jung CW
Int J Hematol; 2001 Dec; 74(4):416-20. PubMed ID: 11794697
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.
Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Earley CL; Winn RJ; Brooks J; Baez L; Hong WK
Ann Oncol; 1995 Jan; 6(1):83-5. PubMed ID: 7536031
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract][Full Text] [Related]
39. [Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up].
Ebeling O; Eckel HE; Volling P; Heitmann K; Vössing M
HNO; 1994 Oct; 42(10):629-35. PubMed ID: 8002371
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
